Search

everythinglearnresearchcommunity

for

Search:↓

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Suppressing certain hormones might help prevent prostate cancer.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

MK-R7 supplement with Cistanche Tubulosa and Laminaria Japonica extracts improved hair density and scalp health without adverse effects.

Hair loss gene linked to prostate issues.

Finasteride effectively treats male hair loss, increasing length and thickness.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Finasteride treats hair loss but may affect prostate cancer detection.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

The nutritional supplement improved hair quality and reduced hair loss.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.